"/> Novus Biologicals™ Peptide bloquant d’anticorps MA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps MARVELD1

Réf. : BL-RE-052705Réf. fabricant : 18218365 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
83742
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76243. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the amino terminus of human MARVELD1.

Points forts

Source

Synthetic

(Accession #: EAW49903) The MARVELD1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-052705
Réf. fabricant18218365
Gene ID (Entrez)83742
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76243. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènebA548K23.8, FLJ22343, FLJ23440, GB14, MARVD1, MARVEL (membrane-associating) domain containing 1, MARVEL domain containing 1, MGC4415, MRVLDC1, putative MARVEL domain-containing protein 1, RP11-548K23.8
Symbole de gène(s)MARVELD1
Type de produitMARVELD1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the amino terminus of human MARVELD1
Une question, une configuration particulière ?
Contactez-nous pour un devis.